Abstract
While treatment options exist for solidary or disseminated KS disease, there are currently no standardized clinical treatment guidelines for limited cutaneous KS. This systematic review seeks to identify safe and effective topical treatments for cutaneous KS lesions. We ascertained the following information if available: type of topical treatment, patient age and sex, number of cases, HIV status, type of KS, known presence of extracutaneous involvement, drug response, drug regimen, timeline of sustained response, and drug-related adverse side effects.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
